News about "testosterone replacement therapy "

Lipocine Signs License Deal with SPC Korea to Commercialize TLANDO in South Korea

Lipocine Signs License Deal with SPC Korea to Commercialize TLANDO in South Korea

Under the terms of the distribution and license agreement, Lipocine will receive an upfront payment and is also eligible to receive certain regulatory and sales milestone payments, including payment upon regulatory approval of TLANDO in South Korea.

Testosterone Replacement Therapy | 04/11/2024 | By Aishwarya 363


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members